Valuation: ResMed, Inc.

Market Cap 3.04TCr 2.65TCr 2.46TCr 2.26TCr 4.27TCr 2,90500Cr 4.34TCr 29TCr 11TCr 1,44600Cr 11TCr 11TCr 4,84900Cr P/E 2026 *
19.9x
P/E 2027 * 18.6x
Enterprise Value 2.96TCr 2.57TCr 2.4TCr 2.2TCr 4.15TCr 2,82600Cr 4.22TCr 28TCr 11TCr 1,40700Cr 11TCr 11TCr 4,71800Cr EV / Sales 2026 *
5.24x
EV / Sales 2027 * 4.79x
Free-Float
75.61%
Yield 2026 *
1.15%
Yield 2027 * 1.24%
1 day+1.16%
1 week+8.05%
1 month+0.64%
3 months+2.91%
6 months-17.18%
Current year-12.41%
1 week 204.6
Extreme 204.6
217.1
1 month 190.21
Extreme 190.21
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
09/02/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
04/02/26 Sell

Founder

2,000 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
+2.32%+8.05%-24.43%-5.03% 3.04TCr
+1.15%+1.06%+24.03%+3.71% 21TCr
+1.55%+1.82%-1.07%-24.39% 14TCr
+5.76%+4.69%-26.86%+12.57% 12TCr
+3.65%+5.60%-55.67%-7.68% 6.95TCr
+2.54%+4.16%+8.50%+7.08% 4.96TCr
+6.02%+7.82%-17.08%-20.95% 4.72TCr
+1.13%-0.14%+21.91%+8.35% 3.91TCr
+0.49%+0.70%+29.97%+29.32% 3.7TCr
-0.27%+5.67%+116.67%+8.20% 3.1TCr
Average +0.67%+3.67%+7.60%+1.12% 7.78TCr
Weighted average by Cap. +0.44%+3.01%+2.81%-0.83%

Financials

2026 *2027 *
Net sales 565.08Cr 491.22Cr 457.22Cr 419.78Cr 792.73Cr 54TCr 805.01Cr 5.39TCr 2.12TCr 27TCr 2.12TCr 2.08TCr 90TCr 599.46Cr 521.11Cr 485.04Cr 445.33Cr 840.96Cr 57TCr 853.99Cr 5.72TCr 2.24TCr 28TCr 2.25TCr 2.2TCr 96TCr
Net income 154.63Cr 134.42Cr 125.12Cr 114.87Cr 216.93Cr 15TCr 220.29Cr 1.47TCr 578.82Cr 7.35TCr 580.73Cr 567.98Cr 25TCr 160.77Cr 139.75Cr 130.08Cr 119.43Cr 225.53Cr 15TCr 229.03Cr 1.53TCr 601.78Cr 7.64TCr 603.77Cr 590.51Cr 26TCr
Net Debt -83Cr -72Cr -67Cr -61Cr -115.97Cr -7.89TCr -117.76Cr -788.42Cr -309.43Cr -3.93TCr -310.46Cr -303.64Cr -13TCr -174.32Cr -151.53Cr -141.05Cr -129.5Cr -244.55Cr -17TCr -248.33Cr -1.66TCr -652.51Cr -8.28TCr -654.67Cr -640.29Cr -28TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
03/26/03 $216.11 +2.43% 78,605
31/26/31 $210.98 +1.16% 11,13,759
30/26/30 $208.56 -2.67% 10,91,211
29/26/29 $214.29 +2.55% 13,25,347
28/26/28 $208.96 +2.90% 11,37,281
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
210.98USD
Average target price
248.53USD
Spread / Average Target
+17.80%

Quarterly revenue - Rate of surprise